theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Radiation Oncology

CML   

Questions discussed in this category


In patients with CML on imatinib and newly diagnosed breast cancer now requiring radiation therapy, should we hold imatinib?
The said patient has been on Imatinib for 2.5 years and is In MMR. Last rt-PCR was 0.04.
3 Answers available
13021


Papers discussed in this category


BMC Cancer, 2010 Aug 09
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.

Related Topics in Radiation Oncology

  • Lung Cancer
  • Workload
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.